Megan Reller
Associate Professor, Infectious Diseases and Global Health
Appointment:
Megan Reller
Associate Professor, Infectious Diseases and Global Health
Megan Reller is a medical instructor in infectious diseases and global health at Duke University. She earned her MD at McGill University in Montréal, Québec, a diploma in tropical medicine and hygiene at the University of London School of Hygiene & Tropical Medicine in London, an MPH at Harvard University and PhD in clinical investigation at Johns Hopkins University. She completed her medical residency in internal medicine and pediatrics at the University of Rochester. She completed multiple clinical and research fellowships at Emory University, Harvard Medical School and Johns Hopkins University and Hospital.
Prior to coming to Duke University in 2016, Dr. Reller was an assistant professor in pathology, medicine and international health at Johns Hopkins University. Her current projects include research on severe viral lower respiratory tract infections, rickettsial infections and dengue infection diagnosis.
Publications
-
Narayanasamy S, Veldman TH, Lee MJ, Glover WA, Tillekeratne LG, Neighbors CE, et al. RADx-UP Testing Core: Access to COVID-19 Diagnostics in Community-Engaged Research with Underserved Populations. J Clin Microbiol. 2023 Aug 23;61(8):e0036723.Hurst JH, Brucker A, Zhao C, Driscoll H, Hostetler HP, Phillips M, et al. Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion. Drug Saf. 2023 Mar;46(3):309–18.Tsalik EL, Fiorino C, Aqeel A, Liu Y, Henao R, Ko ER, et al. The Host Response to Viral Infections Reveals Common and Virus-Specific Signatures in the Peripheral Blood. Front Immunol. 2021;12:741837.McCollum ED, Ahmed S, Roy AD, Chowdhury NH, Schuh HB, Rizvi SJR, et al. Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study. Vaccine. 2020 Sep 29;38(42):6508–16.
See more publications at Scholars@Duke